These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 17565632

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC, Berk PD.
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [Abstract] [Full Text] [Related]

  • 23. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
    Loria P, Lonardo A, Bellentani S, Day CP, Marchesini G, Carulli N.
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
    [Abstract] [Full Text] [Related]

  • 24. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G, Stolk RP, Scheenstra R, Sauer PJ.
    Ned Tijdschr Geneeskd; 2008 Nov 08; 152(45):2443-7. PubMed ID: 19051794
    [Abstract] [Full Text] [Related]

  • 25. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
    Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ.
    Diabetes Metab Res Rev; 2006 Nov 08; 22(6):437-43. PubMed ID: 16832839
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Treatment strategies in nonalcoholic fatty liver disease.
    Tilg H, Kaser A.
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar 08; 2(3):148-55. PubMed ID: 16265156
    [Abstract] [Full Text] [Related]

  • 29. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK.
    Am J Gastroenterol; 2009 Apr 08; 104(4):861-7. PubMed ID: 19293782
    [Abstract] [Full Text] [Related]

  • 30. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA, Hadziyannis SJ.
    Expert Rev Gastroenterol Hepatol; 2008 Feb 08; 2(1):59-79. PubMed ID: 19072371
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Non alcoholic fatty liver. A frequent entity with an unknown outcome].
    Barisio D'Angelo MG, Mariel Actis A, Outomuro D.
    Rev Gastroenterol Peru; 2009 Feb 08; 29(1):44-50. PubMed ID: 19424408
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Non-alcoholic steatohepatitis and metabolic syndrome.
    Machado M, Cortez-Pinto H.
    Curr Opin Clin Nutr Metab Care; 2006 Sep 08; 9(5):637-42. PubMed ID: 16912563
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Pediatric non-alcoholic fatty liver disease: recent advances and challenges].
    Poggiogalle E, Olivero G, Anania C, Ferraro F, Pacifico L.
    Minerva Pediatr; 2010 Dec 08; 62(6):569-84. PubMed ID: 21042270
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.